Jane Street Group, LLC Arbutus Biopharma Corp Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$2.42 - $3.98 $245,872 - $404,368	-101,600 Reduced 44.41%	127,200 $379,000
Q4 2021 Feb 15, 2022	BUY	$3.11 - $4.61 $550,470 - $815,970	177,000 Added 341.7%	228,800 $890,000
Q3 2021 Nov 16, 2021	SELL	$2.65 - $4.62 $21,995 - $38,346	-8,300 Reduced 13.81%	51,800 $222,000
Q1 2021 May 18, 2021	SELL	$3.14 - $4.84 $290,764 - $448,184	-92,600 Reduced 60.64%	60,100 $200,000
Q4 2020 Feb 17, 2021	BUY	$2.76 - $4.97 $421,451 - $758,919	152,700 New	152,700 $542,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.